Sunitha Chari, PhD

Sunitha earned her PhD in Biochemistry from Boston University where she investigated the molecular interactions between low-density lipoprotein receptor and its ligands. She completed her post doctoral training in structural biology and biochemistry at McGill University where she investigated the structure-function relationship of a protein complex involved in cellular transport. After her post-doc she transitioned to scientific communication. She has written on medical and scientific topics for pharma, and non-profit. Sunitha joined Drug Discovery News in November 2021 as Assistant Science Editor and enjoys the combination of intellectual rigour and creative flair her everyday work demands.

Articles by Sunitha Chari, PhD

Immune checkpoint inhibitors regulate the immune system. Antibodies block PD-L1 in red on the surface of a cancer cell and immune checkpoints in blue and violet on a T cell.

Feb 06, 2023|1 min read

By Tiffany Garbutt, PhD, Sunitha Chari, PhD

Explained: How do checkpoint inhibitors work?

Scientists fight against cancer progression using checkpoint inhibitor drugs.

A rear view of a diverse group of friends standing in a line embracing each other in a green, grassy field

Nov 17, 2022|2 min read

By Sunitha Chari, PhD

Social interaction: A basic human need

Healthy relationships are vital for well-being.

Explained: How do Renegade Immune Cells Cause Autoimmune Diseases?

May 08, 2022|1 min read

By Sunitha Chari, PhD

Explained: How do autoimmune disorders arise?

At the frontline of an autoimmune attack are rogue immune cells turned foe against the body they were created to protect. Scientists study the complex etiology of autoimmune disorders to restore the broken balance.

Learn about immune checkpoints and how scientists use them to develop new anticancer therapeutics

Feb 16, 2022|1 min read

By Sunitha Chari, PhD, Tiffany Garbutt, PhD

Explained: How do checkpoint inhibitors work?

Scientists fight against cancer progression using checkpoint inhibitor drugs.